Arvinas (ARVN) Non-Current Assets (2017 - 2026)

Arvinas' (ARVN) quarterly Non-Current Assets came in at $16.8 million in Q1 2026, down 21.5% year-on-year from $21.4 million in Q1 2025, and down 2.33% quarter-over-quarter from $17.2 million in Q4 2025.

Arvinas (ARVN) Non-Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Non-Current Assets history runs 10 years deep, the most recent figure standing at $16.8 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 21.5% year-over-year to $16.8 million in Q1 2026; TTM through Mar 2026 was $71.8 million, a 16.51% decrease from a year earlier, with the FY2025 full-year figure at $17.2 million, down 28.63% from the prior year.
  • Non-Current Assets eased to $16.8 million in Q1 2026 per ARVN's latest filing, from $17.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $31.3 million in Q1 2022 and bottomed at $16.8 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $24.1 million (2024), against an average of $23.8 million.
  • Across the five-year window, Non-Current Assets jumped 87.81% in 2022 and slumped 30.43% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $28.6 million in 2022, then fell by 14.69% to $24.4 million in 2023, then dropped by 1.23% to $24.1 million in 2024, then retreated by 28.63% to $17.2 million in 2025, then dropped by 2.33% to $16.8 million in 2026.
  • Per Business Quant, the three latest ARVN Non-Current Assets figures stand at $16.8 million (Q1 2026), $17.2 million (Q4 2025), and $18.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 16.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.80 Mn
Dec 31, 2025 17.20 Mn
Sep 30, 2025 18.00 Mn
Jun 30, 2025 19.80 Mn
Mar 31, 2025 21.40 Mn
Dec 31, 2024 24.10 Mn
Sep 30, 2024 17.60 Mn
Jun 30, 2024 22.90 Mn
Mar 31, 2024 22.30 Mn
Dec 31, 2023 24.40 Mn
Sep 30, 2023 25.30 Mn
Jun 30, 2023 26.80 Mn
Mar 31, 2023 27.60 Mn
Dec 31, 2022 28.60 Mn
Sep 30, 2022 30.10 Mn
Jun 30, 2022 30.60 Mn
Mar 31, 2022 31.30 Mn
Dec 31, 2021 29.10 Mn
Sep 30, 2021 28.71 Mn
Jun 30, 2021 16.29 Mn